Anti-sebum activity of Nia-Zelaic Oil Control Face Serum

Not Applicable

Not yet recruiting

• Conditions: Not Applicable

• Registration Number: CTRI/2025/06/089160
• Lead Sponsor: Honasa Consumer Limited

Brief Summary

A single blind one arm study.

Each participant entering the trial will be assigned to a regimen of investigational product with the below assessments.



Product is applied on half of the face, and no product is applied on the other half, with sebum assessment at different timepoints to study the comparative reduction in sebum production.



- Sebum by Sebumeter

Assessment Time: T0min, T+3 hr, T+6 hr

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-06-18
• Study Start: 2025-06-30

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

• 1. Gender: Male or Female with age 18-45 2) Subjects with oily skin.
• 3. Subjects willing to give written informed consent 4) Women of child bearing potential must have a negative urine pregnancy test prior to study entry.
• 5. Are free of any systemic or dermatologic disorder, which, in the opinion of the investigator, will interfere with the study results or increase the risk of adverse events.
• 6. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion Criteria

• Subjects who are pregnant, breast-feeding, or planning to become pregnant during the study.
• Have any evidence of systemic cancer, squamous cell carcinoma, basal cell carcinoma, in the last 5 years, or any other confounding skin condition.
• Have open sores or open lesions in the treatment area(s).
• Have any condition that, in the opinion of the investigator, would confound the safety and/or efficacy assessments of the product.
• Have participated in any interventional clinical trial in the previous 90 days.
• Have a known sensitivity to any of the constituents of the test product including sensitivities to product ingredients 7.
• Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including corticosteroids.
• Have not skin related issues.

Study & Design

• Study Type: PMS
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Change in Sebum	At Day1 T0, T3hrs, T6hrs

Secondary Outcome Measures

Name	Time	Method
Not Applicable	Not Applicable

Trial Locations

Locations (1)

CCFT laboratories; 🇮🇳 Meerut, UTTAR PRADESH, India

CCFT laboratories

🇮🇳Meerut, UTTAR PRADESH, India

Dr Robin Chugh

Principal investigator

9027285265

robinderm25@gmail.com